The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PROFILE: Broadly based genomic testing for all patients at a major cancer center.
Barrett J Rollins
Consultant or Advisory Role - Merrimack
Laura E. MacConaill
No relevant relationships to disclose
Nikhil Wagle
Consultant or Advisory Role - Foundation Medicine
Stock Ownership - Foundation Medicine
Elizabeth Garcia
No relevant relationships to disclose
Frank C Kuo
No relevant relationships to disclose
Janina A Longtine
No relevant relationships to disclose
Judy Ellen Garber
Research Funding - Myriad Genetics
Katherine A. Janeway
No relevant relationships to disclose
Charles S. Fuchs
Consultant or Advisory Role - Amgen; Bayer; Celgene; Genentech; Metamark Genetics; Momenta Pharmaceuticals; POZEN; Sanofi
Monica M. Bertagnolli
No relevant relationships to disclose
Robert Soiffer
No relevant relationships to disclose
Ursula Matulonis
No relevant relationships to disclose
Nancy U. Lin
No relevant relationships to disclose
William C Hahn
Consultant or Advisory Role - Blueprint Medicines; Novartis; Thermo Fisher Scientific
Levi A. Garraway
Consultant or Advisory Role - Foundation Medicine; Novartis
Stock Ownership - Foundation Medicine
Philip W. Kantoff
No relevant relationships to disclose
Neal Ian Lindeman
No relevant relationships to disclose